Gan & Lee Pharmaceuticals News and Activities

Gan & Lee Pharmaceuticals is one of the...

• CSI 500;
• TOB Iconic 10,000.

Gan & Lee Pharmaceuticals is a company listed under the stock ticker 603087 (CN).

View the org chart displaying its 13 main executives

Most searched biographies at Gan & Lee Pharmaceuticals

• Haiya Wu, Vice President
• Zhou Li, Acting Chief Financial Officer
• John Wang, Senior Vice President and Chief Strategy Officer

Popular executive movements at Gan & Lee Pharmaceuticals

• John Wang has joined the company as Senior Vice President and Chief Strategy Officer  (posted on January 30 2026).
• Zhou Li has joined the company as Acting Chief Financial Officer  (posted on January 30 2026).
• Ting Jia has joined the company as Chief Medical Officer  (posted on October 20 2025).

Create your alert
to follow the executive moves at Gan & Lee Pharmaceuticals.

Gan & Lee Pharmaceuticals has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Oak Hill Bio has just announced a $33 Million fundraising (posted on June 4 2026).
• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Patrick Enright - Director at CuraSen Therapeutics

Learn more about the Biotechnology industry

Press releases by Gan & Lee Pharmaceuticals

Social media about Gan & Lee Pharmaceuticals

• Gan & Lee Pharmaceuticals on Wikipedia, Google News & Yahoo Finance
• Gan & Lee Pharmaceuticals on LinkedIn, X (Twitter) & YouTube